JELLY BEANS GROUP Co.,Ltd. [3070.T]
TOKYO, Jun 18 (Pulse News Wire) – Jelly Beans Group CO.,LTD. (3070.T) has secured exclusive rights to distribute the Korean femcare brand iHEAL in Japan through a tripartite agreement with AIDEN LAB JAPAN and BIOLAB Corp.
The deal grants JELLY BEANS GROUP the sole distribution and marketing rights within Japan, positioning the company as the country's total agent. The partnership combines JELLY BEANS GROUP’s experience in women's footwear with iHEAL’s patented probiotics and brand strength to tap into the rapidly growing femcare market. Scheduled to launch in the second half of fiscal year 2027, the collaboration leverages iHEAL’s popularity in Korea, where it has achieved top rankings on Olive Young and Qoo10 platforms.
In Japan, iHEAL won the overall ranking on Qoo10 twice consecutively in 2024 and 2025. The company plans to expand sales channels gradually, focusing initially on online and wholesale distribution before broadening its reach across multiple channels. BIOLAB, founded in 2018, specializes in research and manufacturing of femcare probiotics, while AIDEN LAB JAPAN, established in October 2025, handles imports and official circulation in Japan.
The anticipated impact on revenue and profits from this venture is currently being assessed and will be disclosed promptly if significant changes occur.
🟢 Confidence: High AI-translated content.